J&J Talc Bankruptcy Plan Appeal Denied

Seeking Alpha22:31 ET

AC Immune Stock Climbs 7% on FDA Fast Track Status for Alzheimer's Drug

Seeking Alpha12:51 ET

This Is What Whales Are Betting On Gilead Sciences

BenzingaJul 25 11:06 ET

Looking Into Johnson & Johnson's Recent Short Interest

BenzingaJul 25 09:15 ET

AbbVie Raises Outlook as New Immunology Drugs Offset Humira Impact

Seeking AlphaJul 25 08:19 ET

Newly-Listed Psoriasis Alumis Attracts Analysts' Attention With Promising Lead Program And Modest Valuation

BenzingaJul 24 15:18 ET